The all-cash deal adds divesiran, a late-stage-ready rare-disease therapy, to Merck KGaA's pipeline and signals a new wave of RNA therapeutics M&A.

The journalist who exposed Theranos says the Oscar-buzzed film is art, not evidence, and the distinction matters for anyone weighing a founder's story.

Tyler Shultz's allegation adds a fresh twist to the Theranos saga, underscoring how the founder's deception extended even to documentary filmmakers.

The documentary about Elizabeth Holmes' final days before prison opened in under 1,000 theaters and still pulled $15 million.

The anchor tenant's exit leaves Nscale's flagship Essex project in doubt and signals how grid constraints are reshaping AI infrastructure deals.